MD-18

· Cohen Global, Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MD-18, covering 2024-10-01 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes [Phase 1]